Schlieben, S <br/><br/>
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.  [electronic resource] 

 -  Leukemia  Jun 1996 
 - 957-63 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asparaginase--administration & dosage<br/>Base Sequence<br/>Child<br/>Child, Preschool<br/>Chromosomes, Human, Pair 22<br/>Chromosomes, Human, Pair 9<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Fusion Proteins, bcr-abl--genetics<br/>Germany<br/>Humans<br/>Incidence<br/>Infant<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Mercaptopurine--administration & dosage<br/>Methotrexate--administration & dosage<br/>Molecular Sequence Data<br/>Polymerase Chain Reaction<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Prospective Studies<br/>Transcription, Genetic<br/>Translocation, Genetic<br/>Vincristine--administration & dosage